Ineffectiveness of myrrh-derivative Mirazid against schistosomiasis and fascioliasis in humans
EMHJ-Eastern Mediterranean Health Journal. 2010; 16 (9): 932-936
em Inglês
| IMEMR
| ID: emr-158523
ABSTRACT
The present study assessed the schistosomicidal and fasciolicidal actions of the myrrh-derivative Mirazid in an area of low schistosomiasis transmission. A total of 27 patients infected with Schistosoma mansoni and 16 with Fasciola spp. received the maximum recommended dose of Mirazid. Pretreatment egg counts in 4 Kato-Katz slides were compared with similar counts in stool samples collected 1 and 2 months after treatment. Standard procedures and quality control measures were followed. The results revealed that Mirazid used as schistosomicidal or fasciolicidal agent in the maximum recommended dose has a low cure rate and produced a negligible reduction in egg counts. Prescribing such an ineffective drug in Egypt might endanger the achievements of the schistosomiasis control strategy
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Extratos Vegetais
/
Resultado do Tratamento
/
Fasciolíase
Limite:
Adolescente
/
Adulto
/
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
East Mediterr Health J.
Ano de publicação:
2010
Similares
MEDLINE
...
LILACS
LIS